[HTML][HTML] Evidence for the management of bronchopulmonary dysplasia in very preterm infants

T Muehlbacher, D Bassler, MB Bryant - Children, 2021 - mdpi.com
Background: Very preterm birth often results in the development of bronchopulmonary
dysplasia (BPD) with an inverse correlation of gestational age and birthweight. This very …

Interventions to prevent bronchopulmonary dysplasia in preterm neonates: an umbrella review of systematic reviews and meta-analyses

T Abiramalatha, VV Ramaswamy… - JAMA …, 2022 - jamanetwork.com
Importance Bronchopulmonary dysplasia (BPD) has multifactorial etiology and long-term
adverse consequences. An umbrella review enables the evaluation of multiple proposed …

Prevention of bronchopulmonary dysplasia in extremely low gestational age neonates: current evidence

CF Poets, L Lorenz - Archives of Disease in Childhood-Fetal and …, 2018 - fn.bmj.com
Bronchopulmonary dysplasia (BPD) is one of the most frequent complications in extremely
low gestational age neonates, but has remained largely unchanged in rate. We reviewed …

Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies

CT D'Angio, WM Maniscalco - Pediatric drugs, 2004 - Springer
Bronchopulmonary dysplasia (BPD) has classically been described as including
inflammation, architectural disruption, fibrosis, and disordered/delayed development of the …

[HTML][HTML] Turkish Neonatal Society guideline on prevention and management of bronchopulmonary dysplasia

S Arsan, A Korkmaz, S Oğuz - Turkish Archives of Pediatrics/Türk …, 2018 - ncbi.nlm.nih.gov
Scientific and technological advances in perinatology and neonatology have led to an
increased rate of survival and decreased incidences of various neonatal morbidities …

Advances in treating bronchopulmonary dysplasia

E Williams, A Greenough - Expert review of respiratory medicine, 2019 - Taylor & Francis
Introduction: Bronchopulmonary dysplasia (BPD) is a common long-term adverse
complication of very premature delivery. Affected infants can suffer chronic respiratory …

[HTML][HTML] Pharmacotherapy in bronchopulmonary dysplasia: what is the evidence?

RP Sakaria, R Dhanireddy - Frontiers in Pediatrics, 2022 - frontiersin.org
Bronchopulmonary Dysplasia (BPD) is a multifactorial disease affecting over 35% of
extremely preterm infants born each year. Despite the advances made in understanding the …

Prevention of bronchopulmonary dysplasia: a summary of evidence-based strategies

EA Jensen - Neoreviews, 2019 - publications.aap.org
Bronchopulmonary dysplasia (BPD) is the most common chronic complication associated
with extremely preterm birth. Although BPD is now an uncommon condition in infants born …

[HTML][HTML] Bronchopulmonary dysplasia in extremely premature infants: A scoping review for identifying risk factors

M Ito, S Kato, M Saito, N Miyahara, H Arai, F Namba… - Biomedicines, 2023 - mdpi.com
Background: Over the years, bronchopulmonary dysplasia (BPD) affects the pulmonary
function of infants, resulting in chronic health burdens for infants and their families. The aim …

A systematic review of randomized controlled trials for the prevention of bronchopulmonary dysplasia in infants

KS Beam, S Aliaga, SK Ahlfeld… - Journal of …, 2014 - nature.com
Objective: Bronchopulmonary dysplasia (BPD) is the most common cause of pulmonary
morbidity in premature infants and is associated with life-long morbidities. Developing drugs …